Armata Pharmaceuticals (ARMP) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.71% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -0.31% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 29.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.40% |
| Dec 31, 2025 | 49.95% |
| Sep 30, 2025 | 42.51% |
| Jun 30, 2025 | 57.23% |
| Mar 31, 2025 | 78.93% |
| Dec 31, 2024 | 81.35% |
| Sep 30, 2024 | 86.26% |
| Jun 30, 2024 | 85.09% |
| Mar 31, 2024 | 81.76% |
| Dec 31, 2023 | 83.07% |
| Sep 30, 2023 | 68.02% |
| Jun 30, 2023 | 64.02% |
| Mar 31, 2023 | 39.45% |
| Dec 31, 2022 | 18.26% |
| Sep 30, 2022 | 19.71% |
| Jun 30, 2022 | -1.74% |
| Mar 31, 2022 | 74.95% |
| Dec 31, 2021 | -11.92% |
| Sep 30, 2021 | 52.77% |
| Jun 30, 2021 | 46.34% |
| Mar 31, 2021 | 42.76% |
| Dec 31, 2020 | 35.88% |
| Sep 30, 2020 | 32.04% |
| Jun 30, 2020 | 29.98% |
| Mar 31, 2020 | 26.86% |
| Dec 31, 2019 | 26.83% |
| Sep 30, 2019 | 29.98% |
| Jun 30, 2019 | 41.55% |
| Mar 31, 2019 | -28.93% |
| Dec 31, 2018 | 42.16% |
| Sep 30, 2018 | -20.18% |
| Jun 30, 2018 | -16.08% |
| Mar 31, 2018 | -15.31% |
| Dec 31, 2017 | -12.55% |
| Sep 30, 2017 | -12.93% |
| Jun 30, 2017 | -6.69% |
| Mar 31, 2017 | 40.24% |
| Dec 31, 2016 | 94.81% |